Delivery Order V797D70252-75H71121F80062
Award Date 11/30/20
Potential Completion Date 2/11/21
Potential Value $3.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Foster City, CA 94404, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. (Gilead) for the emergency procurement of the antiviral drug remdesivir (Veklury). The contract has a potential value of $194,625.00 and a completion date of December 31, 2020. This order is placed against Gilead's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Gilead, a biopharmaceutical company, has...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for Veklury (remdesivir) to treat COVID-19, with a potential value of $194,625.00. As a Firm Fixed Price contract, Gilead will deliver the pharmaceutical product directly to VA medical facilities in Carrollton, TX. The award is not associated with a set-aside designation....
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded Gilead Sciences Inc. a $136,237.50 firm-fixed-price delivery order contract for Veklury (remdesivir), a COVID-19 treatment. This order was placed against Gilead's existing Multiple Award Schedule (MAS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Gilead, a biopharmaceutical company, is the prime contractor and will directly provide the medication, with performance taking place in Foster City, California. This...
- The Department of Veterans Affairs Veterans Health Administration awarded a $291,937.50 firm fixed price delivery order to Gilead Sciences Inc. for the supply of the Veklury (remdesivir) drug for the treatment of COVID-19 patients. This delivery order was placed under Gilead's existing General Services Administration (GSA) Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). As a prime contractor, Gilead will directly provide the Veklury injections to VA medical facilities...
- This is a delivery order contract awarded by the Department of Veterans Affairs to Gilead Sciences Inc. to provide Veklury (remdesivir) for COVID-19 treatment. The contract has a firm fixed price of $155,700.00 and a completion date of January 31, 2021. Gilead is a biopharmaceutical company that provides pharmaceuticals and biologics to government customers through its GSA Schedule contract. Gilead has received numerous federal contracts from the VA to supply antiviral and oncology...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc., a biopharmaceutical company, for the supply of the COVID-19 antiviral medication Veklury (remdesivir). The order has a firm-fixed price of $155,700.00 and a completion date of October 29, 2021. The contract was awarded on December 9, 2020 and is placed under Gilead's existing General Services Administration (GSA) Multiple Award Schedule contract for...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc., a large biopharmaceutical company. The contract is for the supply of Veklury (remdesivir), a COVID-19 treatment medication. The contract has a ceiling value of $77,850.00 and was awarded on December 23, 2020, with a completion date of January 22, 2021. The contract was awarded under GSA Schedule 61-IB for Pharmaceuticals...
- This is a federal contract award to Gilead Sciences Inc., a biopharmaceutical company, for the provision of REMDESIVIR 100MG SOLID. The contract was awarded on December 4, 2020 by the Department of Veterans Affairs Veterans Health Administration, with a potential value of $233,550.00. The contract is a Delivery Order under Gilead's General Services Administration (GSA) Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), indicating that Gilead is an established supplier of...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 9 (VISN 9), part of the U.S. Department of Veterans Affairs (VA), to Gilead Sciences Inc. for the emergency procurement of the drug remdesivir. The contract has a ceiling value of $77,850.00 and was awarded on January 8, 2021, with a completion date of January 16, 2021. The contract was placed under GSA Schedule 61-IB for Pharmaceuticals and Drugs and utilized a firm fixed-price pricing type. This...
- This is a firm fixed-price delivery order for 100MG REMDESIVIR LYOPHILIZED SOLID, awarded by the Department of Veterans Affairs Veterans Health Administration to the prime contractor Gilead Sciences Inc. The contract has a potential value of $116,775.00 and a completion date of March 30, 2021. The award was made under Gilead's existing GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). This order is part of the VA's efforts to procure medications to address the Coronavirus COVID-19...